"cdsco"

Public health experts have sounded an alarm over counterfeit Abhayrab rabies vaccines linked to batch KE25012, urging patients vaccinated on or after November 7, 2025, to verify authenticity with healthcare providers. The CDSCO seized spurious vials from an unlicensed premises in Delhi, with Indian Immunologicals confirming multiple packaging discrepancies.

Four widely used Central Nervous System medications, including Zopiclone and Gabapentin, have been placed under Schedule H1 controls amid concerns over over-the-counter availability and off-label intoxication. Chemists will have to follow stricter prescription, record-keeping and warning-label requirements for these drugs.

The Centre has directed states and Union Territories to strengthen monitoring of the supply chain and promotion of GLP-1 weight-loss drugs. Regulators have also been asked to act against surrogate advertisements and misleading campaigns that encourage unsupervised use of prescription medicines

India has granted market authorisation to Takeda Biopharmaceuticals’ dengue vaccine QDENGA, making it the country’s first approved vaccine for dengue prevention. The approval by CDSCO follows extensive global and Indian clinical trials confirming its safety and efficacy.

The CDSCO has warned that cosmetic products are strictly prohibited from being used as injections, stating such practices violate the Drugs and Cosmetics Act. The regulator clarified that cosmetics are only meant for topical application, not for therapeutic treatments.

The CDSCO has issued a public advisory after a batch of Sanofi’s Lantus SoloStar insulin was stolen during transit from Odisha to Kolkata. Authorities warn that improper storage outside the 2–8°C cold chain could compromise the drug’s safety and efficacy.

India’s drug regulator, the CDSCO, has issued a safety advisory for thyroid patients, warning of potentially life-threatening side effects from carbimazole and doxycycline. Manufacturers have also been directed to update packaging with clear warnings.

TGDCA, in coordination with the CDSCO, raided Bluesemi Research and Development Pvt. Ltd. in Raidurg, Rangareddy district, uncovering unlicensed manufacturing and sale of medical devices.

The Union Health Ministry has eased pharmaceutical regulations, allowing companies to start drug development and low-risk clinical studies via online intimation to CDSCO, cutting approval timelines, reducing regulatory burden, and boosting research and innovation in the Indian pharma sector

Anger is rising over India’s drug regulators for failing to issue a public advisory on counterfeit Abhayrab rabies vaccines. Despite alerts from Indian Immunologicals Limited, authorities chose a quiet probe, prompting ethical concerns after global warnings were issued by foreign regulators.

AIIMS Delhi experts announced that the Supernova Stent, developed by Gravity Medical Technology, has proven safe and effective in treating severe strokes. Approved by CDSCO earlier this year, the stent will now be manufactured in India at affordable prices.

The Central Drugs Standard Control Organisation (CDSCO) has announced that morning-after contraceptive pills will continue to be sold over-the-counter (OTC) in India, but with mandatory warning labels. These warnings, printed in regional languages and accessible via QR codes, caution against overuse and clarify that the pills do not protect against HIV or other sexually transmitted infections.

In the wake of child deaths linked to allegedly contaminated cough syrups, the Central Drugs Standard Control Organisation (CDSCO) has launched a pan-India drive to audit, inspect, and ensure compliance by cough syrup manufacturers, urging states to submit their company lists

Following child deaths in Madhya Pradesh and Rajasthan allegedly linked to contaminated Coldrif cough syrup, CDSCO has launched inspections across six States. Tamil Nadu and Madhya Pradesh have banned the syrup, while authorities investigate manufacturing lapses and advise caution for paediatric use

The Centre has issued a nationwide advisory cautioning against prescribing cough and cold medications to children under two years, following reports of child deaths allegedly linked to contaminated syrups in Madhya Pradesh. Investigations are ongoing, with multi-agency teams probing all possible causes.

Union Minister Anupriya Patel clarified in Parliament that CDSCO has not banned paracetamol in India, countering recent rumours. While certain Fixed Dose Combinations involving paracetamol are restricted, standalone paracetamol remains approved for use.

The Drugs and Cosmetics Act of 1940 is inadequate to deal with the complexities of modern pharma market

The agreement for the collection of plasma etc from blood centres for analytical purposes and study samples shall be maintained by the BA/BE Centres/CROs along with relevant SOPs and labels used in this regard.

The CDSCO, in collaboration with various State DCAs, including the Telangana Drug Control Administration (TSDCA) conducted quality tests on random 1,167 drug samples in February, of which 58 turned out to be NSQs and 2 samples were spurious.

58% of fixed-dose combination of antibiotics sold across India are on the WHO’s ‘not recommended’ list